Compare LIVN & MC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LIVN | MC |
|---|---|---|
| Founded | 1987 | 2007 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.3B | 4.1B |
| IPO Year | 2015 | 2014 |
| Metric | LIVN | MC |
|---|---|---|
| Price | $78.50 | $58.38 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 11 | 11 |
| Target Price | ★ $90.55 | $67.30 |
| AVG Volume (30 Days) | 517.2K | ★ 1.1M |
| Earning Date | 11-04-2026 | 11-05-2026 |
| Dividend Yield | N/A | ★ 4.33% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.33 | 0.75 |
| Revenue | N/A | N/A |
| Revenue This Year | $9.65 | $13.79 |
| Revenue Next Year | $7.10 | $17.73 |
| P/E Ratio | ★ $35.01 | $79.71 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $48.82 | $51.06 |
| 52 Week High | $85.76 | $78.22 |
| Indicator | LIVN | MC |
|---|---|---|
| Relative Strength Index (RSI) | 50.35 | 54.19 |
| Support Level | $74.69 | $57.70 |
| Resistance Level | $82.39 | $70.99 |
| Average True Range (ATR) | 2.20 | 2.04 |
| MACD | 0.26 | 0.83 |
| Stochastic Oscillator | 48.00 | 75.36 |
UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives approximately half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.
Moelis & Co is an independent investment bank that provides strategic and financial advice to a diverse client base, including corporations, financial sponsors, governments, and sovereign wealth funds. The company assists its clients in achieving their strategic goals by offering comprehensive, globally integrated financial advisory services across all industry sectors. It also advises clients on their critical decisions, including mergers and acquisitions, recapitalizations and restructurings, capital markets transactions, and other corporate finance matters. It generates revenue from advisory transactions. The firm derives a majority of its revenue from the United States, followed by Europe and the rest of the World.